Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies

Publication date: Available online 28 August 2020Source: Cancer CellAuthor(s): Jingwen Si, Xiangjun Shi, Shuhao Sun, Bin Zou, Yaopeng Li, Dongjie An, Xingyu Lin, Yan Gao, Fei Long, Bo Pang, Xing Liu, Tian Liu, Wenna Chi, Ligong Chen, Dimiter S. Dimitrov, Yan Sun, Xinru Du, Wen Yin, Guangxun Gao, Junxia Min
Source: Cancer Cell - Category: Cancer & Oncology Source Type: research